IVIG Reduces Grade 2 Infections by 67 Percent in CLL
A study has found that intravenous immune globulin (IVIG) reduces grade 2 infections by 67 percent in patients with chronic lymphocytic leukemia.
Study Finds Flu Vaccine Sharply Reduces Infections in Children Ages 2 to 5
A study has found pediatric flu vaccines significantly reduce the number of childhood cases of influenza.
Cancer Vaccine Produces 49 Percent Melanoma Reduction in Patients
A study has found the combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, is successful in cutting the risk of skin cancer recurrence and death by 49 percent.
Study Finds Moderna and Pfizer/BioNTech COVID-19 Vaccines 70 to 76 Percent Effective Against Severe Illness in Kids
A recent study in Taiwan that examined the vaccine effectiveness (VE) against moderate to severe COVID-19 infection in children aged 6 to 11 years found the Pfizer/BioNTech BNT162b2 VE was 69.9 percent and the Moderna mRNA-1273 VE was 75.5 percent during Omicron BA.2/BA.5 predominance in 2022.
Reduced Risk of Dementia Linked to Eight Vaccines
According to multiple large observational studies, the risk of dementia is associated with eight routine adult vaccines: the shingles, respiratory syncytial virus, influenza, DTP (diphtheria, tetanus and pertussis), pneumococcal, hepatitis A, hepatitis B and typhoid vaccines.
Takeda’s TAK-881 SCIG Product Meets Primary and Secondary Endpoints in Phase II/III Clinical Trial
Takeda’s pivotal Phase II/III clinical trial of its investigational TAK-881K SCIG 20% with recombinant human hyaluronidase) in patients with primary immunodeficiency met its primary and secondary endpoints.
FDA Approves Expanded Label for ASCENIV for PI Patients 2 Years and Older
The U.S. Food and Drug Administration has approved ADMA Biologics’ supplemental biologics license application to expand the prescribing information to primary humoral immunodeficiency indication to pediatric patients 2 years of age and older.
New Bill Introduced to Ensure Dedicated Payment for IVIG in Skilled Nursing Facilities
U.S. Representatives Adrian Smith (R-NE-03) and Doris Matsui (D-CA-07) have introduced the PI Post Acute Access Act to expand access to lifesaving care for individuals with primary immunodeficiencies
IVIG Results in Improved Response Rate in Patients with Autoimmune Encephalitis
Intravenous immune globulin (IVIG) improved clinical response rates in patients with autoimmune encephalitis (AE) who had inadequate response to steroid pulse therapy.
Researchers Awarded $900,000 Grant to Develop Drug to Fight Cancer
Wei Gao, PhD, assistant professor of pharmacology at the University of Houston College of Pharmacy, has received a $900,000 grant from the Cancer Prevention and Research Institute of Texas to develop a stronger and more targeted anti-tumor therapy for pancreatic and lung cancer.